Works in Clinical Pharmacology & Therapeutics, 2006, Vol 80, Issue 3

Results: 14

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 203, doi. 10.1016/j.clpt.2006.05.008

By:

Lappin, Graham;
Kuhnz, Wilhelm;
Jochemsen, Roeline;
Kneer, Johannes;
Chaudhary, Ajai;
Oosterhuis, Berend;
Drijfhout, Willem Jan;
Rowland, Malcolm;
Garner, R. Colin

Publication type:

Article

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 216, doi. 10.1016/j.clpt.2006.05.007

By:

Bauer, Martin;
Langer, Oliver;
Dal-Bianco, Peter;
Karch, Rudolf;
Brunner, Martin;
Abrahim, Aiman;
Lanzenberger, Rupert;
Hofmann, Andrea;
Joukhadar, Christian;
Carminati, Paolo;
Ghirardi, Orlando;
Piovesan, Paola;
Forloni, Gianluigi;
Corrado, Mario E.;
Lods, Nadège;
Dudczak, Robert;
Auff, Eduard;
Kletter, Kurt;
Müller, Markus

Publication type:

Article

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 228, doi. 10.1016/j.clpt.2006.06.002

By:

Kurnik, Daniel;
Wood, Alastair J. J.;
Wilkinson, Grant R.

Publication type:

Article

Liver disease selectively modulates cytochrome P450–mediated metabolism*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 235, doi. 10.1016/j.clpt.2006.05.006

By:

Frye, Reginald F.;
Zgheib, Nathalie K.;
Matzke, Gary R.;
Chaves-Gnecco, Diego;
Rabinovitz, Mordechai;
Shaikh, Obaid S.;
Branch, Robert A.

Publication type:

Article

Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 246, doi. 10.1016/j.clpt.2006.05.013

By:

Sidharta, Patricia N.;
Wagner, Frank D.;
Bohnemeier, Holger;
Jungnik, Arvid;
Halabi, Atef;
Krähenbühl, Stephan;
Chadha-Boreham, Harbajan;
Dingemanse, Jasper

Publication type:

Article

Validation of incorporating flurbiprofen into the Pittsburgh cocktail*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 257, doi. 10.1016/j.clpt.2006.06.005

By:

Zgheib, Nathalie K.;
Frye, Reginald F.;
Tracy, Timothy S.;
Romkes, Marjorie;
Branch, Robert A.

Publication type:

Article

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 264, doi. 10.1016/j.clpt.2006.05.004

By:

Renda, Giulia;
Tacconelli, Stefania;
Capone, Marta L.;
Sacchetta, Daniele;
Santarelli, Francesco;
Sciulli, Maria G.;
Zimarino, Marco;
Grana, Marilena;
D'Amelio, Elisabetta;
Zurro, Maria;
Price, Thomas S.;
Patrono, Carlo;
De Caterina, Raffaele;
Patrignani, Paola

Publication type:

Article

Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritis*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 275, doi. 10.1016/j.clpt.2006.05.011

By:

Cardillo, Carmine;
Schinzari, Francesca;
Mores, Nadia;
Mettimano, Marco;
Melina, Domenico;
Zoli, Angelo;
Ferraccioli, Gianfranco

Publication type:

Article

Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations*.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 282, doi. 10.1016/j.clpt.2006.05.012

By:

Nakajima, Miki;
Fukami, Tatsuki;
Yamanaka, Hiroyuki;
Higashi, Eriko;
Sakai, Haruko;
Yoshida, Ryoko;
Kwon, Jun-Tack;
McLeod, Howard L.;
Yokoi, Tsuyoshi

Publication type:

Article

Is celecoxib an inducer of cytochrome P450 3A4 in subjects carrying the CYP2C9*3 allele?

Published in:

2006

By:

Rodrigues, A. David;
Zheng Yang;
Chen, Cliff;
Pray, Devin;
Kim, Sean;
Sinz, Michael

Publication type:

Letter

Reply.

Published in:

2006

By:

Eliasson, Erik;
Lundblad, Mia Sandberg

Publication type:

Letter

Imaging P-glycoprotein at the human blood-brain barrier.

Published in:

2006

By:

Franssen, Eric J. F.;
Luurtsema, Gert;
Lammertsma, Adriaan A.

Publication type:

Letter

Reply.

Published in:

2006

By:

Unadkat, Jashvant D.;
Link, Jeanne M.;
Mankoff, David A.;
Muzi, Mark;
Collier, Ann C.

Publication type:

Letter

A Message from The ASCPT Membership Committee Chairperson.

Published in:

Clinical Pharmacology & Therapeutics, 2006, v. 80, n. 3, p. 305, doi. 10.1016/j.clpt.2006.08.001

By:

Vincent, John

Publication type:

Article

Works in Clinical Pharmacology & Therapeutics, 2006, Vol 80, Issue 3

Use of microdosing to predict pharmacokinetics at the therapeutic dose: Experience with 5 drugs<sup>*</sup>.

A positron emission tomography microdosing study with a potential antiamyloid drug in healthy volunteers and patients with Alzheimer's disease<sup>*</sup>.

The erythromycin breath test reflects P-glycoprotein function independently of cytochrome P450 3A activity<sup>*</sup>.

Liver disease selectively modulates cytochrome P450–mediated metabolism<sup>*</sup>.

Pharmacodynamics and pharmacokinetics of the urotensin II receptor antagonist palosuran in macroalbuminuric, diabetic patients.

Validation of incorporating flurbiprofen into the Pittsburgh cocktail<sup>*</sup>.

Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease<sup>*</sup>.

Intravascular tumor necrosis factor α blockade reverses endothelial dysfunction in rheumatoid arthritis<sup>*</sup>.

Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations<sup>*</sup>.

Is celecoxib an inducer of cytochrome P450 3A4 in subjects carrying the CYP2C9<sup>*</sup>3 allele?

Reply.

Imaging P-glycoprotein at the human blood-brain barrier.

Reply.

A Message from The ASCPT Membership Committee Chairperson.